News

Harbour BioMed (HBM) announced completion of a Phase 1 study of HBM9161, a fully human anti-FcRn monoclonal antibody, to evaluate its safety, tolerability, pharmacokinetics and…
Read More...

Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-cell redirecting cancer immunotherapies, announced it has entered…
Read More...

Vifor Pharma announced a strategic partnership with Fresenius Kabi to create a new joint company based in the People’s Republic of China expanding its access to the second largest…
Read More...

Roche announced that the US Food and Drug Administration (FDA) has accepted the company’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq…
Read More...

LumaCyte, an advanced bioanalytical instrumentation company specializing in vaccine and cell and gene therapy bioprocess, production, and R&D analytical capabilities, announces its…
Read More...

Hummingbird Bioscience, an innovative biotherapeutics company pioneering the discovery of new breakthrough antibody therapeutics for difficult-to-treat conditions, announced it has…
Read More...

FORMA Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced the U.S. Food and Drug Administration (FDA) has granted…
Read More...

Humanetics Corporation (Humanetics) announced that it has entered into a definitive agreement with DSM Nutritional Products Ltd of Kaiseraugst Switzerland to acquire all of DSM’s assets…
Read More...

Five Prime Therapeutics, Inc. announced a global license agreement with Seattle Genetics, Inc. to develop and commercialize novel antibody-drug conjugate (ADC) therapies using…
Read More...

NeoTX Therapeutics, a clinical-stage biotechnology company leveraging its proprietary Selective T cell Redirection (STR) platform to develop targeted anticancer immunotherapies, has…
Read More...

Nimble Therapeutics, Inc. announced a multi-year collaboration with Genentech, a member of the Roche Group, to accelerate discovery and development of novel peptide-based medicines for…
Read More...

St. Louis startup Pluton Biosciences, LLC is pleased to announce that it has acquired Microbe Inotech Laboratories (MiL), Inc., a full-service microbiological lab also headquartered in…
Read More...

Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international pharmaceutical company,…
Read More...

Biotage AB (Biotage) announced the launch of a Good Laboratory Practices (GLP) software upgrade for Biotage Extrahera, their flagship automated sample preparation instrument for…
Read More...

Aphena Pharma Solutions Inc. has announced the expansion of its bottling capacity with the purchase of a new, state-of-the-art, high-speed, solid-dose bottling line with an integrated…
Read More...

m8 Pharmaceuticals and Vectans Pharma, announced they have signed an exclusive licensing agreement whereby m8 will have the rights to register and commercialize Loramyc (miconazole) for…
Read More...

Sanofi Pasteur, the vaccines global business unit of Sanofi, will leverage previous development work for a SARS vaccine which may unlock a fast path forward for developing a COVID-19…
Read More...

Audentes Therapeutics, an Astellas company focused on developing innovative AAV-based genetic medicines, announced that it plans to invest $109 million to build a new 135,000 square…
Read More...

Pfizer Inc. announced that the European Commission (EC) has approved VYNDAQEL (tafamidis), a once-daily 61 mg oral capsule, for the treatment of wild-type or hereditary transthyretin…
Read More...

Arrevus, a clinical stage biopharmaceutical company committed to the development of innovative therapies to treat orphan or serious diseases, announced that the U.S. Food and Drug…
Read More...